...
首页> 外文期刊>Infection and immunity >Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.
【24h】

Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

机译:葡萄球菌肠毒素的催吐和T细胞刺激活性之间缺乏完全相关性。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This study examined the emetic activity of several staphylococcal enterotoxin type A and B (SEA and SEB, respectively) mutants that had either one or two amino acid residue substitutions. New sea gene mutations were constructed by site-directed mutagenesis; gene products were obtained with glycine residues at position 25, 47, 48, 81, 85, or 86 of mature SEA. Culture supernatants from Staphylococcus aureus RN4220, or derivatives containing either sea or a sea mutation, were analyzed for the ability to stimulate proliferation of murine splenocytes, as determined by incorporation of [3H]thymidine. Culture supernatants containing SEA-N25G (a SEA mutant with a substitution of glycine for the asparagine residue at position 25), SEA-F47G, or SEA-L48G did not stimulate T-cell proliferation, unlike supernatants containing the other substitution mutants. Purified preparations of SEA-N25G had weak activity and those of SEA-F47G and SEA-L48G had essentially no activity in the T-cell proliferation assay. All mutants except SEA-V85G, which was degraded by monkey stomach lavage fluid in vitro, were tested for emetic activity. SEA-C106A and two SEB mutants, SEB-D9N/N23D and SEB-F44S (previously referred to as BR-257 and BR-358, respectively), whose construction and altered immunological properties have been reported previously, were also tested in the emetic assay. Each mutant was initially administered intragastrically at doses of 75 to 100 micrograms per animal; if none of the animals responded, the dose was increased four-to fivefold. SEA-F47G, SEA-C106A, and SEB-D9N/N23D were the only mutants that did not induce vomiting at either dose tested; these three mutants had reduced immunological activity. However, there was not a perfect correlation between immunological and emetic activities; SEA-L48G and SEB-F44S retained emetic activity, although they had essentially no T-cell-stimulatory activity. These studies suggest that these two activities can be dissociated.
机译:这项研究检查了几种具有一个或两个氨基酸残基取代的A和B型葡萄球菌肠毒素(分别为SEA和SEB)的催吐活性。通过定点诱变构建新的海基因突变;获得的基因产物在成熟SEA的25、47、48、81、85或86位上带有甘氨酸残基。通过掺入[3 H]胸苷,分析了来自金黄色葡萄球菌RN4220或含有海或海突变的衍生物的培养物上清液刺激鼠脾细胞增殖的能力。与含有其他取代突变体的上清液不同,含有SEA-N25G(用甘氨酸替代25位天冬酰胺残基的SEA突变体),SEA-F47G或SEA-L48G的培养物上清液不会刺激T细胞增殖。在T细胞增殖试验中,纯化的SEA-N25G制剂的活性较弱,而SEA-F47G和SEA-L48G的制剂基本上无活性。测试了除SEA-V85G以外的所有突变体(其在体外被猴胃灌洗液降解)的催吐活性。还在催吐物中测试了SEA-C106A和两个SEB突变体SEB-D9N / N23D和SEB-F44S(分别以前称为BR-257和BR-358),其结构和改变的免疫学性质先前已报道过。分析。每个突变体最初以每只动物75到100微克的剂量经胃内给药。如果没有动物反应,则剂量增加四到五倍。 SEA-F47G,SEA-C106A和SEB-D9N / N23D是在任一测试剂量下均不引起呕吐的仅有突变体。这三个突变体的免疫活性降低。但是,免疫和催吐活性之间并没有完美的关联。 SEA-L48G和SEB-F44S保留了催吐活性,尽管它们基本上没有T细胞刺激活性。这些研究表明,这两种活动可以分离。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号